[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0917745D0 - Compositions for the prevention or treatment of migraine - Google Patents

Compositions for the prevention or treatment of migraine

Info

Publication number
GB0917745D0
GB0917745D0 GBGB0917745.2A GB0917745A GB0917745D0 GB 0917745 D0 GB0917745 D0 GB 0917745D0 GB 0917745 A GB0917745 A GB 0917745A GB 0917745 D0 GB0917745 D0 GB 0917745D0
Authority
GB
United Kingdom
Prior art keywords
migraine
prevention
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0917745.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATHILDE VALAYER
Original Assignee
MATHILDE VALAYER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATHILDE VALAYER filed Critical MATHILDE VALAYER
Priority to GBGB0917745.2A priority Critical patent/GB0917745D0/en
Publication of GB0917745D0 publication Critical patent/GB0917745D0/en
Priority to PCT/GB2010/001881 priority patent/WO2011042701A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0917745.2A 2009-10-09 2009-10-09 Compositions for the prevention or treatment of migraine Ceased GB0917745D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0917745.2A GB0917745D0 (en) 2009-10-09 2009-10-09 Compositions for the prevention or treatment of migraine
PCT/GB2010/001881 WO2011042701A1 (en) 2009-10-09 2010-10-07 Compositions for the prevention or treatment of migraine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0917745.2A GB0917745D0 (en) 2009-10-09 2009-10-09 Compositions for the prevention or treatment of migraine

Publications (1)

Publication Number Publication Date
GB0917745D0 true GB0917745D0 (en) 2009-11-25

Family

ID=41402816

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0917745.2A Ceased GB0917745D0 (en) 2009-10-09 2009-10-09 Compositions for the prevention or treatment of migraine

Country Status (2)

Country Link
GB (1) GB0917745D0 (en)
WO (1) WO2011042701A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011163301A1 (en) 2010-06-25 2011-12-29 Global Healthcare Focus, Llc Methods of treating optic disorders
CA2876169C (en) * 2011-06-21 2023-01-24 Global Healthcare Focus, Llc Methods of preventing or treating disease states related to certain metabolic abnormalities
US20150209374A1 (en) 2014-01-29 2015-07-30 Faro Owiesy Composition and Method for Curing Migraine Headaches
WO2018130865A1 (en) * 2017-01-13 2018-07-19 The Hospital For Sick Children Pediatric headache treatment and method
WO2019000101A1 (en) * 2017-06-29 2019-01-03 Msi Methylation Sciences Inc. Novel formulations useful in treating folate deficiencies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064000A (en) 1959-04-14 1962-11-13 Sankyo Kabushiki Kaisha S-benzoylthiamine o-monophosphate and a process for preparing the same
US6517832B1 (en) 2001-08-24 2003-02-11 Jeffrey L. Marrongelle Formulations and methods for treating chronic migraine
US20080206360A1 (en) 2004-12-01 2008-08-28 Curt Hendrix Folate based migraine treatment
KR101758624B1 (en) * 2007-03-22 2017-07-14 뉴로센트리아, 인크. Magnesium compositions and uses thereof

Also Published As

Publication number Publication date
WO2011042701A1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
EP2440209A4 (en) Compositions and methods for the prevention and treatment of heart failure
IL225471B (en) Compositions for the prevention and treatment of cancer
ZA201204625B (en) Analogues for the treatment or prevention of flavivirus infections
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
IL217503A0 (en) Benzimidazole analogues for the treatment or prevention of flavivirus infections
GB0802403D0 (en) Compositions for the treatment of oxidative stress
EP2273880A4 (en) Novel formulations for treatment of migraine
IL210997A0 (en) Compositions for the treatment of mrsa and uses thereof
HK1170490A1 (en) Pharmaceutical composition for treating or preventing glaucoma
EP2558085A4 (en) Compositions and methods for the prevention and treatment of cancer
HK1167662A1 (en) Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids
IL214349A0 (en) Compositions and methods for the treatment of cancer
SI2605764T1 (en) Compositions for the treatment of cancer
IL209360A (en) Pharmaceutical compositions comprising pm00104 for the treatment of multiple myeloma
HK1165320A1 (en) Composition for treatment and/or prevention of dermatopathy
EP2437738A4 (en) Methods and compositions for the treatment of cancer
RS55057B1 (en) Composition for the treatment of infertility
GB0917745D0 (en) Compositions for the prevention or treatment of migraine
EP2285398A4 (en) Methods and compositions for the treatment of obesity
HU0900231D0 (en) Compositions for the treatment of allergic disorders
EP2271328A4 (en) Antiseptic compositions for the treatment of infections
EP2412378A4 (en) Composition for prevention or treatment of insomnia
IL208624A0 (en) Compositions for the treatment of lice
EP2411031A4 (en) Methods and compositions for the treatment of cancer
EP2459507A4 (en) Use of erythritol for the prevention or treatment of hypertension

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)